BioSpace News Archive

Today, Samsung kicked off the 9th annual Samsung Solve for Tomorrow Contest, which challenges 6th – 12th grade U.S. public school teachers to submit ideas for how their students can use STEM (science, technology, engineering, and math) to solve problems in their communities.

Aflac, the leader in voluntary insurance sales at U.S. worksites, today delivered the very first My Special Aflac Ducks™ to the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta.

Regen BioPharma Inc. has filed a patent application covering composition of matter and methods of use related to molecules identified in its small molecule program that activate NR2F6.

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that it will present at the following September investor conferences:

Puma Biotechnology, Inc. announced that on September 5, 2018 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 31,125 shares of Puma common stock to four new non-executive employees.

Incyte Corporation (Nasdaq:INCY) today announced that David Gryska, Executive Vice President and Chief Financial Officer, intends to retire at the end of 2018 and that Incyte has launched a search for his replacement.

Luminex Corporation today announced that Homi Shamir, President and Chief Executive Officer, and Harriss Currie, Senior Vice President and Chief Financial Officer, will participate in an analyst-led fireside chat at the Morgan Stanley 16th Annual Global Healthcare Conference to be held September 12-14, 2018 in New York, NY.

Advaxis, Inc. announced today that it intends to offer and sell in an underwritten public offering shares of its common stock, with each share of common stock to be sold together in a fixed combination with a warrant to purchase common stock.

Tiny microbubbles used as ultrasound contrast agents can help patients with liver or kidney masses avoid follow up computed tomography (CT) or magnetic resonance (MR) scans and significantly reduce healthcare costs, according to a study described today at an international physician’s conference in Chicago.

The Feinstein Institute for Medical Research researchers published data yesterday in the Journal of Experimental Medicine that shows the class of drugs commonly used to treat hypertension, ACE inhibitors, can block cognitive decline in mice and might therefore be used to preserve the memory of patients living with lupus.